Skip to main navigation Skip to search Skip to main content

An Open-label, Single-Arm, Phase 2 Study to Evaluate the Combination of ABT-450/r/ABT-267 and ABT-333 Coadministered with Ribavirin (RBV) in Adults with Genotype 1 Hepatitis C Virus (HCV) Infection taking Methadone or Buprenorphine

Project: Research

Project Details

StatusFinished
Effective start/end date06/13/1312/31/14

Funding

  • AbbVie Incorporated: $6,200.00